{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:13:24Z","timestamp":1779329604878,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00127-022-02409-5","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:02:58Z","timestamp":1671804178000},"page":"1493-1502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-3795","authenticated-orcid":false,"given":"Thomas Wolff","family":"Rosenqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-220X","authenticated-orcid":false,"given":"Merete","family":"Osler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-4356","authenticated-orcid":false,"given":"Marie Kim","family":"Wium-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-4999","authenticated-orcid":false,"given":"Ida Kim","family":"Wium-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"2409_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.12594","volume":"26","author":"D Riemann","year":"2017","unstructured":"Riemann D, Baglioni C, Bassetti C et al (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26:675\u2013700","journal-title":"J Sleep Res"},{"key":"2409_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3949\/ccjm.88a.20031","volume":"88","author":"V Modesto-Lowe","year":"2021","unstructured":"Modesto-Lowe V, Harabasz AK, Walker SA (2021) Quetiapine for primary insomnia: consider the risks. Cleve Clin J Med 88:286\u2013294","journal-title":"Cleve Clin J Med"},{"key":"2409_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0740-5472(91)90027-8","volume":"8","author":"M Lader","year":"1991","unstructured":"Lader M (1991) History of benzodiazepine dependence. J Subst Abuse Treat 8:53\u201359","journal-title":"J Subst Abuse Treat"},{"key":"2409_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","volume":"6","author":"A Schmitz","year":"2016","unstructured":"Schmitz A (2016) Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin 6:120\u2013126","journal-title":"Ment Health Clin"},{"key":"2409_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","volume":"9","author":"N Gunja","year":"2013","unstructured":"Gunja N (2013) The clinical and forensic toxicology of Z-drugs. J Med Toxicol 9:155\u2013162","journal-title":"J Med Toxicol"},{"key":"2409_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S2215-0366(19)30331-1","volume":"6","author":"J Marsden","year":"2019","unstructured":"Marsden J, White M, Annand F et al (2019) Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England. Lancet Psychiatry 6:935\u2013950","journal-title":"Lancet Psychiatry"},{"key":"2409_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","volume":"22","author":"F Schifano","year":"2019","unstructured":"Schifano F, Chiappini S, Corkery JM et al (2019) An insight into Z-drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions. Int J Neuropsychopharmacol 22:270\u2013277","journal-title":"Int J Neuropsychopharmacol"},{"key":"2409_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TAT Kurko","year":"2015","unstructured":"Kurko TAT, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S et al (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies. Eur Psychiatry 30:1037\u20131047","journal-title":"Eur Psychiatry"},{"key":"2409_CR9","first-page":"1","volume":"112","author":"K Janhsen","year":"2015","unstructured":"Janhsen K, Roser P, Hoffmann K (2015) The problems of long-term treatment with benzodiazepines and related substances. Dtsch Arzteblatt Int 112:1\u20137","journal-title":"Dtsch Arzteblatt Int"},{"key":"2409_CR10","doi-asserted-by":"publisher","first-page":"e000850","DOI":"10.1136\/bmjopen-2012-000850","volume":"2","author":"DF Kripke","year":"2012","unstructured":"Kripke DF, Langer RD, Kline LE (2012) Hypnotics\u2019 association with mortality or cancer: a matched cohort study. BMJ Open 2:e000850","journal-title":"BMJ Open"},{"key":"2409_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/arclin\/acx120","volume":"33","author":"SF Crowe","year":"2018","unstructured":"Crowe SF, Stranks EK (2018) The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol 33:901\u2013911","journal-title":"Arch Clin Neuropsychol"},{"key":"2409_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","volume":"36","author":"LPH Andersen","year":"2016","unstructured":"Andersen LPH, G\u00f6genur I, Rosenberg J et al (2016) The safety of melatonin in humans. Clin Drug Investig 36:169\u2013175","journal-title":"Clin Drug Investig"},{"key":"2409_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1755-5949.2011.00234.x","volume":"17","author":"TL Schwartz","year":"2011","unstructured":"Schwartz TL, Stahl SM (2011) Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther 17:110\u2013117","journal-title":"CNS Neurosci Ther"},{"key":"2409_CR14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/bcp.13945","volume":"85","author":"M H\u00f8jlund","year":"2019","unstructured":"H\u00f8jlund M, Potteg\u00e5rd A, Johnsen E et al (2019) Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016. Br J Clin Pharmacol 85:1598\u20131606","journal-title":"Br J Clin Pharmacol"},{"key":"2409_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/JCP.0000000000000338","volume":"35","author":"J Kamphuis","year":"2015","unstructured":"Kamphuis J, Taxis K, Schuiling-Veninga CCM et al (2015) Off-label prescriptions of low-dose quetiapine and mirtazapine for insomnia in The Netherlands. J Clin Psychopharmacol 35:468\u2013470","journal-title":"J Clin Psychopharmacol"},{"key":"2409_CR16","first-page":"1552","volume":"17","author":"G Di Iorio","year":"2013","unstructured":"Di Iorio G, Matarazzo I, Di Tizio L et al (2013) Treatment-resistant insomnia treated with pregabalin. Eur Rev Med Pharmacol Sci 17:1552\u20131554","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2409_CR17","first-page":"E9EZ","volume":"115","author":"J H\u00f6jer","year":"2018","unstructured":"H\u00f6jer J, Tellerup M (2018) Ren\u00e4ssans f\u00f6r Lergigan med kraftig \u00f6kning av intoxikationsfall. L\u00e4kartidningen 115:E9EZ","journal-title":"L\u00e4kartidningen"},{"key":"2409_CR18","unstructured":"L\u00e6gemiddelstyrelsen (2014) Antihistaminet promethazin (Phernergan) bliver receptpligtigt. https:\/\/laegemiddelstyrelsen.dk\/da\/nyheder\/2014\/antihistaminet-promethazin-phenergan-mfl-bliver-receptpligtigt\/"},{"key":"2409_CR19","first-page":"441","volume":"53","author":"CB Pedersen","year":"2006","unstructured":"Pedersen CB, Gotzsche H, Moller JO et al (2006) The Danish civil registration system. A cohort of eight million persons. Dan Med Bull 53:441\u20139","journal-title":"Dan Med Bull"},{"key":"2409_CR20","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H et al (2017) Data resource profile: the Danish national prescription registry. Int J Epidemiol 46:798\u2013798f","journal-title":"Int J Epidemiol"},{"key":"2409_CR21","doi-asserted-by":"publisher","first-page":"e213209","DOI":"10.1001\/jamanetworkopen.2021.3209","volume":"4","author":"M H\u00f8jlund","year":"2021","unstructured":"H\u00f8jlund M, Lund LC, Andersen K et al (2021) Association of low-dose quetiapine and diabetes. JAMA Netw Open 4:e213209","journal-title":"JAMA Netw Open"},{"key":"2409_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1590\/1981-22562017020.170042","volume":"20","author":"MM Alvim","year":"2017","unstructured":"Alvim MM, Cruz DT, Vieira MT et al (2017) Prevalence of and factors associated with benzodiazepine use in community-resident elderly persons. Rev Bras Geriatr E Gerontol 20:463\u2013473","journal-title":"Rev Bras Geriatr E Gerontol"},{"key":"2409_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1478-7954-4-15","volume":"4","author":"A Kassam","year":"2006","unstructured":"Kassam A, Patten SB (2006) Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Popul Health Metr 4:15","journal-title":"Popul Health Metr"},{"key":"2409_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12888-022-03964-6","volume":"22","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Chien I-C, Lin C-H (2022) Trends, correlates, and disease patterns of sedative-hypnotic use among elderly persons in Taiwan. BMC Psychiatry 22:316","journal-title":"BMC Psychiatry"},{"key":"2409_CR25","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1017\/S2045796021000159","volume":"30","author":"M H\u00f8jlund","year":"2021","unstructured":"H\u00f8jlund M, Andersen JH, Andersen K et al (2021) Use of antipsychotics in Denmark 1997\u20132018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses. Epidemiol Psychiatr Sci 30:e28","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2409_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","volume":"81","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Sadrameli S, Contreras J et al (2021) Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs 81:125\u2013156","journal-title":"Drugs"},{"key":"2409_CR27","unstructured":"Methods to analyse medicine utilization and expenditure to support pharmaceutical policy implementation. WHO. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274282\/9789241514040-eng.pdf?sequence=1&isAllowed=y"},{"key":"2409_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/00001648-199711000-00013","volume":"8","author":"J Hallas","year":"1997","unstructured":"Hallas J, Gaist D, Bjerrum L (1997) The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 8:666","journal-title":"Epidemiology"},{"key":"2409_CR29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/bcp.13570","volume":"84","author":"CA Cadogan","year":"2018","unstructured":"Cadogan CA, Ryan C, Cahir C et al (2018) Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol 84:1354\u20131363","journal-title":"Br J Clin Pharmacol"},{"key":"2409_CR30","first-page":"1724","volume":"9","author":"T Okui","year":"2021","unstructured":"Okui T, Park J, Hirata A et al (2021) Trends in the prescription of benzodiazepine receptor agonists from 2009 to 2020: a retrospective study using electronic healthcare record data of a university hospital in Japan. Healthc Basel Switz 9:1724","journal-title":"Healthc Basel Switz"},{"key":"2409_CR31","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.3399\/BJGP.2021.0054","volume":"71","author":"M Begum","year":"2021","unstructured":"Begum M, Gonzalez-Chica D, Bernardo C et al (2021) Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011\u20132018. Br J Gen Pract 71:e877\u2013e886","journal-title":"Br J Gen Pract"},{"key":"2409_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/acps.13329","volume":"144","author":"R Wesselhoeft","year":"2021","unstructured":"Wesselhoeft R, Rasmussen L, Jensen PB et al (2021) Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia. Acta Psychiatr Scand 144:100\u2013112","journal-title":"Acta Psychiatr Scand"},{"key":"2409_CR33","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/14656566.2018.1511705","volume":"19","author":"L Frase","year":"2018","unstructured":"Frase L, Nissen C, Riemann D et al (2018) Making sleep easier: pharmacological interventions for insomnia. Expert Opin Pharmacother 19:1465\u20131473","journal-title":"Expert Opin Pharmacother"},{"key":"2409_CR34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","volume":"35","author":"JK Carpenter","year":"2018","unstructured":"Carpenter JK, Andrews LA, Witcraft SM et al (2018) Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety 35:502\u2013514","journal-title":"Depress Anxiety"},{"key":"2409_CR35","first-page":"2133","volume":"179","author":"M J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen M, Videbech P, Osler M (2017) Benzodiazepiner har fortsat en plads i moderne psykiatrisk behandling. Ugeskr Laeger 179:2133\u20132137","journal-title":"Ugeskr Laeger"},{"key":"2409_CR36","doi-asserted-by":"publisher","first-page":"e63773","DOI":"10.1371\/journal.pone.0063773","volume":"8","author":"E Ferracioli-Oda","year":"2013","unstructured":"Ferracioli-Oda E, Qawasmi A, Bloch MH (2013) Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE 8:e63773","journal-title":"PLoS ONE"},{"key":"2409_CR37","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","volume":"22","author":"N Buscemi","year":"2007","unstructured":"Buscemi N, Vandermeer B, Friesen C et al (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22:1335\u20131350","journal-title":"J Gen Intern Med"},{"key":"2409_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/jcpt.12790","volume":"44","author":"R Mukai","year":"2019","unstructured":"Mukai R, Hasegawa S, Umetsu R et al (2019) Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases. J Clin Pharm Ther 44:285\u2013291","journal-title":"J Clin Pharm Ther"},{"key":"2409_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","volume":"27","author":"U Bonnet","year":"2017","unstructured":"Bonnet U, Scherbaum N (2017) How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol 27:1185\u20131215","journal-title":"Eur Neuropsychopharmacol"},{"key":"2409_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.sleep.2009.01.009","volume":"10","author":"IJ Russell","year":"2009","unstructured":"Russell IJ, Crofford LJ, Leon T et al (2009) The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med 10:604\u2013610","journal-title":"Sleep Med"},{"key":"2409_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/NDT.S290104","volume":"17","author":"S Landolt","year":"2021","unstructured":"Landolt S, Rosemann T, Blozik E et al (2021) Benzodiazepine and Z-drug use in Switzerland: prevalence, prescription patterns and association with adverse healthcare outcomes. Neuropsychiatr Dis Treat 17:1021\u20131034","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-022-02409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-022-02409-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-022-02409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T19:02:07Z","timestamp":1693076527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-022-02409-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1007\/s00127-022-02409-5","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"27 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}